Hikma continued strategic progress and updated full-year guidance following Custopharm acquisition

Good business performance gives Boehringer Ingelheim tailwind for investment in R&D

Hikma Ventures leads seed financing round for Egypt based O7 Therapy;...

Hikma Ventures Participates in USD 44 Million Financing Round for Altibbi...

MOH LAUNCHES TWO PROJECTS IN COLLABORATION WITH NOVO NORDISK TO COMBAT...

Survey: 60% of UAE residents worried about managing diabetes post-pandemic

Hikma delivers another year of profitable growth in 2021 and announces...

Hikma expands licensing agreement with Celltrion for Remsima® subcutaneous formulation in...

Johnson & Johnson’s COVID-19 Vaccine Booster Dose Receives Positive CHMP Opinion

Janssen EMEA Receives Conditional Marketing Authorisation for RYBREVANT® ▼ (amivantamab), the...

123...7Page 2 of 7

Connect with us

1,824FansLike
210FollowersFollow
1,929FollowersFollow
30SubscribersSubscribe